Literature DB >> 14991307

[Ocular side effects and complications of intravitreal triamcinolone acetonide injection].

G B Jaissle1, P Szurman, K U Bartz-Schmidt.   

Abstract

With the advent of intravitreal triamcinolone acetonid injections major focus was assigned to potential ocular side effects. The current discussion is dominated by the potential cytotoxicity of particular biologically incompatible components. Those are regarded as substantial pathogenetic factor of the sterile pseudoendophthalmitis that seems to be avoidable by meticulous purification of the commercially available preparations. Even sustained subretinal or epiretinal deposits disclosed no signs of retinal toxicity. Major ocular side effects comprise temporary corticosteroid glaucoma and progressive cataract formation. Infectious endophthalmitis represents a rare but serious complication that might be set into critical context with hygienic surgical standards applied. Due to steroid-induced immune suppression clinical signs of inflammation might be masked and a proper diagnosis delayed. Other rare complications reported include a transient central retinal artery occlusion, conjunctival ulcerations, retinal detachment and potential reactivation of a cytomegalovirus retinitis. In conclusion, ocular side effects and complications show a wide variety of clinical signs and underlying causal mechanisms. However, the consequences are mostly temporary and show a good response to therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991307     DOI: 10.1007/s00347-003-0975-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  46 in total

1.  Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis.

Authors:  S Young; G Larkin; M Branley; S Lightman
Journal:  Clin Exp Ophthalmol       Date:  2001-02       Impact factor: 4.207

2.  Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide.

Authors:  Jost B Jonas; Ingrid Kreissig; Robert Degenring
Journal:  Arch Ophthalmol       Date:  2003-05

3.  Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.

Authors:  Carl H Park; Glenn J Jaffe; Sharon Fekrat
Journal:  Am J Ophthalmol       Date:  2003-09       Impact factor: 5.258

4.  In vivo reactivation of latent murine cytomegalovirus in the eye by immunosuppressive treatment.

Authors:  T Rabinovitch; J O Oh; P Minasi
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-04       Impact factor: 4.799

5.  [Effects of intravitreal steroid injection on rabbit eye].

Authors:  H Shimada; M Matsui
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1989-04

6.  Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids.

Authors:  R Haimovici; E S Gragoudas; J S Duker; R N Sjaarda; D Eliott
Journal:  Ophthalmology       Date:  1997-10       Impact factor: 12.079

7.  Acute endophthalmitis following intravitreal triamcinolone acetonide injection.

Authors:  Darius M Moshfeghi; Peter K Kaiser; Ingrid U Scott; Jonathan E Sears; Matthew Benz; Juan P Sinesterra; Richard S Kaiser; Sophie J Bakri; Raj K Maturi; Jonathan Belmont; Paul M Beer; Timothy G Murray; Hugo Quiroz-Mercado; William F Mieler
Journal:  Am J Ophthalmol       Date:  2003-11       Impact factor: 5.258

8.  Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown.

Authors:  Taiji Sakamoto; Miho Miyazaki; Toshio Hisatomi; Takao Nakamura; Akifumi Ueno; Keiko Itaya; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-03-15       Impact factor: 3.117

Review 9.  Anaphylaxis induced by the carboxymethylcellulose component of injectable triamcinolone acetonide suspension (Kenalog).

Authors:  D L Patterson; J W Yunginger; W F Dunn; R T Jones; L W Hunt
Journal:  Ann Allergy Asthma Immunol       Date:  1995-02       Impact factor: 6.347

10.  Central serous chorioretinopathy in endogenous hypercortisolism.

Authors:  E A Bouzas; M H Scott; G Mastorakos; G P Chrousos; M I Kaiser-Kupfer
Journal:  Arch Ophthalmol       Date:  1993-09
View more
  17 in total

Review 1.  Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.

Authors:  Abhirup Mandal; Rohit Bisht; Ilva D Rupenthal; Ashim K Mitra
Journal:  J Control Release       Date:  2017-01-11       Impact factor: 9.776

2.  [Cystoid macular edema in uveitis].

Authors:  S R Thurau
Journal:  Ophthalmologe       Date:  2005-05       Impact factor: 1.059

3.  [Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe].

Authors:  H P N Scholl; M Fleckenstein; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

4.  Influence of different purification techniques on triamcinolone yield and particle size spectrum.

Authors:  Peter Szurman; Radoslaw Kaczmarek; Gesine B Jaissle; Salvatore Grisanti; Matthias Lüke; Martin S Spitzer; Peter-Edgar Heide; Karl U Bartz-Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-09-28       Impact factor: 3.117

Review 5.  [Intravitreal injection. Monitoring to avoid postoperative complications].

Authors:  C H Meyer; F Ziemssen; H Heimann
Journal:  Ophthalmologe       Date:  2008-02       Impact factor: 1.059

6.  Examination of purification methods and development of intravitreal injection of triamcinolone acetonide.

Authors:  Masako Oishi; Shinichiro Maeda; Ayumi Nakamura; Nobuo Kurokawa; Nobuyuki Ohguro; Yasuo Tano
Journal:  Jpn J Ophthalmol       Date:  2005 Sep-Oct       Impact factor: 2.447

7.  Associated factors and treatment outcome of presumed noninfectious endophthalmitis occurring after intravitreal triamcinolone acetonide injection.

Authors:  Seong Joon Ahn; Tae Wan Kim; Jeeyun Ahn; Jang Won Huh; Hyeong Gon Yu; Hum Chung
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-07-22       Impact factor: 3.117

8.  [Optic atrophy subsequent to epiretinal triamcinolone deposits in an eye following inner limiting membrane peeling].

Authors:  G B Jaissle; K U Bartz-Schmidt; P Szurman
Journal:  Ophthalmologe       Date:  2008-06       Impact factor: 1.059

9.  [Endophthalmitis after repeated bevacizumab injections].

Authors:  K B Schaal; A E Höh; A Scheuerle; S Dithmar
Journal:  Ophthalmologe       Date:  2009-04       Impact factor: 1.059

10.  Effect of intravitreal dexamethasone implant on retinal and choroidal thickness in refractory diabetic macular oedema after multiple anti-VEGF injections.

Authors:  M Kim; Y J Cho; C H Lee; S C Lee
Journal:  Eye (Lond)       Date:  2016-03-04       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.